Total Net Assets: Cortigent Inc (CRGT)

The growth of Cortigent, Inc. (CRGT) relies on unique vision restoration developments, rendering the asset's value independent of market cycles. Price action on GURU.Markets is fixed at while management integrates neural interfaces into clinical practice. A streamlined network of global warehouses ensures stable income by guaranteeing the uninterrupted delivery of equipment to hospitals with high profitability.

CRGT Cortigent Medical Book Capitalization (07/04/2022 - 10/27/2026)

By advancing neuromodulation innovations independently of macroeconomic trends, Cortigent, Inc. creates value through clinical development. This metric is calculated as the difference between total assets and liabilities, reflecting the actual net worth of the business excluding market speculation. By analyzing the company's total book capitalization, an investor assesses the asset's fundamental protection, where high capital reduces risk but limits the probability of explosive growth.

Direct competitors

Biogen Idec (BIIB) - Book Value of Business|NBIX - Company Net Assets|RGC (regencellbioscience.com) - Total Net Assets|Company Book Value Axsome Therapeutics, Inc. (AXSM)|Accounting Capitalization ACADIA Pharma|Xenon Pharmaceuticals Inc - Book Capitalization|Total Stockholders' Equity Viking Therapeutics Corp VKTX|Company Net Assets SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Book Capitalization|Company Book Value Denali Therapeutics Inc. (DNLI)|HRMY: Accounting Value of Company|Company Book Value BHVN|Amylyx Corp (AMLX) - Total Stockholders' Equity|Book Capitalization TRVI|Company Net Assets PRAX|Anavex Life Sciences Corp. - Company Book Value|Total Stockholders' Equity CBLL (CeriBell Inc)|Company Book Value prothena.com|ALEC - Accounting Value of Company|Company Net Assets Annexon, Inc. ANNX|OMER - Total Net Assets|Neurogene - Book Capitalization|AC Immune S.A. (ACIU) - Book Valuation of Business|Voyager Pharma - Book Capitalization|Book Value of Business Neumora Corp|Scilex Holding Company - Book Capitalization|Total Stockholders' Equity TVGN (tevogen.com)|ACOG - Company Book Value|CGTX - Accounting Capitalization|Company Net Assets Inhibikase IKT|Cassava Pharma (SAVA) - Total Net Assets|Company Net Assets assertiotx.com ASRT|Coya Therapeutics (COYA) - Accounting Value of Company|VTGN: Book Capitalization|Book Valuation of Business OVID|Company Book Value Acumen Pharma ABOS|Accounting Capitalization CervoMed Corporation (CRVO)|Alterity Therapeutics Limited - Book Capitalization|CLNN - Company Net Assets|Company Net Assets PEPG (PepGen Corp)|JUNS - Book Valuation of Business|RLMD (Relmada) - Book Capitalization|ANVS (Annovis Bio Corporation) - Company Net Assets|GRCE - Company Book Value|Accounting Value of Company fireflyneuro.com|KLTO: Book Capitalization|Book Value of Business neurosense-tx.com NRSN|Company Net Assets Reviva Pharmaceuticals Holdings (RVPH)|MetaVia Inc. - Total Net Assets|NeurAxis, Inc. (NRXS) - Company Book Value|HSDT - Accounting Capitalization|Book Capitalization PASG|Total Stockholders' Equity Neuphoria Therapeutics|NERV (Minerva Neurosciences Corp) - Company Net Assets|Book Capitalization ATHA|Addex Therapeutics (ADXN) - Company Book Value|Accounting Value of Company ALZN (alzamend.com)|CYCN: Company Book Value|Total Stockholders' Equity Protagenic Therapeutics Inc. PTIX|KTTA: Book Capitalization|ATXI: Company Net Assets|Company Book Value BCLI|CARA (caratherapeutics.com) - Total Stockholders' Equity|CHRO - Company Book Value|Accounting Value of Company Eliem (ELYM)|Company Net Assets Intra-Cellular Therapies|Total Net Assets Longboard (LBPH)|Book Capitalization MRNS|Book Valuation of Business nkgenbiotech.com NKGN|Book Capitalization NRBO|SAGE - Book Value of Business|Book Capitalization SNPX|TRVN (Trevena Inc) - Total Stockholders' Equity|Company Book Value Vigil Neuroscience Inc. (VIGL)|Accounting Capitalization Anew Medical Inc. (WENA)|Company Net Assets Cerevel Therapeutics, Inc.